Personensuche
Personensuche
Es wurde 1 Person gefunden.
Funktionen
-
Nebenberuflich Lehrende/r, Institut für Pharmakologie
Aktuelle Veranstaltungen
Vergangene Veranstaltungen (max. 10)
-
SoSe 2025
-
WiSe 2024
-
SoSe 2024
-
WiSe 2023
-
SoSe 2023
-
WiSe 2022
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Antibacterial therapy in central nervous system infections : Breakpoints versus minimal inhibitory concentrations related to body fluid levelsIn: Infection - A Journal of Infectious Disease, 2025, in press
-
Correction to: High rates of cefiderocol plasma target attainment: results of a retrospective cohort study in 31 critically ill ICU patientsIn: Critical Care: The Online Intensive Care Journal, Jg. 29, 2025, 380DOI (Open Access)
-
Disintegration-dissolution modeling of bilayer tablets : Predicting plasma profiles and antimicrobial efficacy under postprandial conditionsIn: Journal of Pharmaceutical Sciences, Jg. 114, 2025, Nr. 8, 103843
-
Monitoring Plasma Concentrations of Intravenously Administered Fosfomycin to Prevent Drug-Related Adverse Events : A Retrospective Observational StudyIn: Antibiotics, Jg. 14, 2025, Nr. 6, 548DOI (Open Access)
-
Underexposure of linezolid in critically ill patients with extracorporeal membrane oxygenation (ECMO) : results from a monocentric study including blood samples from 52 patientsIn: Infection - A Journal of Infectious Disease, 2025, in press
-
High rates of cefidercol plasma target attainment : results of a retrospective cohort study in 31 critically ill ICU patientsIn: Critical Care: The Online Intensive Care Journal, Jg. 28, 2024, Nr. 1, 438DOI (Open Access)
-
Clinical and demographic factors affecting trough levels of isavuconazole in critically ill patients with or without COVID-19In: Mycoses, Jg. 66, 2023, Nr. 12, S. 1071 – 1078DOI (Open Access)
-
Caffeine, Paraxanthine, Theophylline, and Theobromine Content in Human MilkIn: Nutrients, Jg. 14, 2022, Nr. 11, 2196DOI (Open Access)
-
Pharmacokinetics of Nirmatrelvir and Ritonavir in COVID-19 Patients with End-Stage Renal Disease on Intermittent HemodialysisIn: Antimicrobial Agents and Chemotherapy, Jg. 66, 2022, Nr. 11, e0122922DOI (Open Access)
-
SARS-CoV-2 viral load dynamics in immunocompromised critically ill patients on remdesivir treatmentIn: Multidisciplinary Respiratory Medicine, Jg. 17, 2022, 825DOI (Open Access)
-
Central nervous system infections and antimicrobial resistance : An evolving challengeIn: Current Opinion in Neurology, Jg. 34, 2021, Nr. 3, S. 456 – 467
-
Penetration of isavuconazole in ascites fluid of critically ill patientsIn: Journal of Fungi, Jg. 7, 2021, Nr. 5, 376DOI (Open Access)
-
Pharmacokinetics of remdesivir in a COVID-19 patient with end-stage renal disease on intermittent haemodialysisIn: Journal of Antimicrobial Chemotherapy, Jg. 76, 2021, Nr. 3, S. 825 – 827DOI (Open Access)
-
A Novel Study Design Using Continuous Intravenous and Intraduodenal Infusions of Midazolam and Voriconazole for Mechanistic Quantitative Assessment of Hepatic and Intestinal CYP3A InhibitionIn: Journal of Clinical Pharmacology, Jg. 60, 2020, Nr. 9, S. 1237 – 1253DOI (Open Access)
-
In Vitro Recovery of Sufentanil, Midazolam, Propofol, and Methylprednisolone in Pediatric Cardiopulmonary Bypass SystemsIn: Journal of Cardiothoracic and Vascular Anesthesia, Jg. 34, 2020, Nr. 4, S. 972 – 980DOI (Open Access)
-
Physiologically Based Population Pharmacokinetic Modeling Approach for Ciprofloxacin in Bone of Patients Undergoing Orthopedic SurgeryIn: ACS Pharmacology & Translational Science, Jg. 3, 2020, Nr. 3, S. 444 – 454DOI, Online Volltext (Open Access)
-
The parent drugs chloroquine and hydroxychloroquine do not inhibit human CYP3A activity in vitroIn: European Journal of Clinical Pharmacology, Jg. 76, 2020, Nr. 10, S. 1481 – 1482DOI (Open Access)
-
4-Methylumbelliferone improves the thermogenic capacity of brown adipose tissueIn: Nature Metabolism, Jg. 1, 2019, Nr. 5, S. 546 – 559DOI, Online Volltext (Open Access)
-
A Clinical Drug-Drug Interaction Study Assessing a Novel Drug Transporter Phenotyping Cocktail With Adefovir, Sitagliptin, Metformin, Pitavastatin, and DigoxinIn: Clinical Pharmacology & Therapeutics, Jg. 106, 2019, Nr. 6, S. 1398 – 1407
-
A HILIC-MS/MS assay for the quantification of metformin and sitagliptin in human plasma and urine : A tool for studying drug transporter perturbationIn: Journal of Pharmaceutical and Biomedical Analysis, Jg. 175, 2019, S. 112754
-
A long-time stability study of 50 drug substances representing common drug classes of pharmaceutical useIn: Drug Testing and Analysis, Jg. 11, 2019, Nr. 7, S. 1065 – 1075
-
A systematic review of the stability of finished pharmaceutical products and drug substances beyond their labeled expiry datesIn: Journal of Pharmaceutical and Biomedical Analysis, Jg. 166, 2019, S. 222 – 235
-
Assessment of pharmacokinetic drug-drug interactions in humans : In vivo probe substrates for drug metabolism and drug transport revisitedIn: Annual Review of Pharmacology and Toxicology, Jg. 59, 2019, S. 507 – 536
-
Comparable Bioavailability and Disposition of Pefloxacin in Patients with Cystic Fibrosis and Healthy Volunteers Assessed via Population PharmacokineticsIn: Pharmaceutics, Jg. 11, 2019, Nr. 7, 323DOI (Open Access)
-
Four Decades of β-Lactam Antibiotic Pharmacokinetics in Cystic FibrosisIn: Clinical Pharmacokinetics, Jg. 58, 2019, Nr. 2, S. 143 – 156
-
Influence of sustained low-efficiency dialysis treatment on isavuconazole plasma levels in critically Ill patientsIn: Antimicrobial Agents and Chemotherapy, Jg. 63, 2019, Nr. 11, S. e01162 – 19DOI, Online Volltext (Open Access)
-
N-glycans of complex glycosylated biopharmaceuticals and their impact on protein clearanceIn: European Journal of Pharmaceutics and Biopharmaceutics, Jg. 139, 2019, S. 123 – 131DOI (Open Access)
-
Novel population pharmacokinetic approach to explain the differences between cystic fibrosis patients and healthy volunteers via protein bindingIn: Pharmaceutics, Jg. 11, 2019, Nr. 6, 286DOI (Open Access)
-
Quantification of adefovir and pitavastatin in human plasma and urine by LC-MS/MS : A useful tool for drug-drug interaction studiesIn: Journal of Chromatography B, Jg. 1125, 2019, S. 121718
-
Regorafenib CSF Penetration, Efficacy, and MRI Patterns in Recurrent Malignant Glioma PatientsIn: Journal of Clinical Medicine (JCM), Jg. 8, 2019, Nr. 12, 2031DOI (Open Access)
-
The contamination of valsartan and other sartans, Part 2 : Untargeted screening reveals contamination with amides additionally to known nitrosamine impuritiesIn: Journal of Pharmaceutical and Biomedical Analysis, Jg. 172, 2019, S. 278 – 284
-
The contamination of valsartan and other sartans, part 1 : New findingsIn: Journal of Pharmaceutical and Biomedical Analysis, Jg. 172, 2019, S. 395 – 405
-
A stability-study of expired ampoules manufactured more than 40 years agoIn: Journal of Pharmaceutical and Biomedical Analysis, Jg. 150, 2018, S. 318 – 326
-
Azathioprine-induced reversible EBV-associated Hodgkin-like lymphoma after immunosuppressive therapy for autoimmune hepatitisIn: International Journal of Clinical Pharmacology and Therapeutics, Jg. 56, 2018, Nr. 3, S. 142 – 147
-
Drinking Ethanol Has Few Acute Effects on CYP2C9, CYP2C19, NAT2, and P-Glycoprotein Activities but Somewhat Inhibits CYP1A2, CYP2D6, and Intestinal CYP3A : So What?In: Clinical Pharmacology & Therapeutics, Jg. 104, 2018, Nr. 6, S. 1249 – 1259
-
First population pharmacokinetic analysis showing increased quinolone metabolite formation and clearance in patients with cystic fibrosis compared to healthy volunteersIn: European Journal of Pharmaceutical Sciences, Jg. 123, 2018, S. 416 – 428
-
Quantification of Hydrochlorothiazide and Ramipril/Ramiprilate in Blood Serum and Cerebrospinal Fluid : A Pharmacokinetic Assessment of Central Nervous System Adverse EffectsIn: Pharmacology, Jg. 102, 2018, Nr. 3-4, S. 133 – 137
-
Quantification of bisoprolol and metoprolol in simultaneous human serum and cerebrospinal fluid samplesIn: Pharmacology, Jg. 101, 2018, Nr. 1-2, S. 29 – 34DOI (Open Access)
-
Environmental pollution with antimicrobial agents from bulk drug manufacturing industries in Hyderabad, South India, is associated with dissemination of extended-spectrum beta-lactamase and carbapenemase-producing pathogensIn: Infection - A Journal of Infectious Disease, Jg. 45, 2017, Nr. 4, S. 479 – 491
-
Pharmakokinetik und Pharmakodynamik von Antibiotika in der IntensivmedizinIn: Medizinische Klinik - Intensivmedizin und Notfallmedizin, Jg. 112, 2017, Nr. 1, S. 11 – 22
-
Population modeling integrating pharmacokinetics, pharmacodynamics, pharmacogenetics, and clinical outcome in patients with sunitinib-treated cancerIn: CPT: Pharmacometrics and Systems Pharmacology, Jg. 6, 2017, Nr. 9, S. 604 – 613DOI (Open Access)
-
Severe Drug-Induced Liver Injury as an Adverse Drug Event of Antibiotics : a Case Report and Review of the LiteratureIn: Chemotherapy, Jg. 62, 2017, Nr. 6, S. 367 – 373
-
Ten years of biosimilars in Europe : development and evolution of the regulatory pathwaysIn: Drug Design, Development and Therapy, Jg. 11, 2017, S. 1509 – 1515DOI (Open Access)
-
Comparison of Pantoprazole Concentrations in Simultaneous Cerebrospinal Fluid and Serum SamplesIn: Pharmacology, Jg. 98, 2016, Nr. 1-2, S. 70 – 72
-
Dosing to rash? : The role of erlotinib metabolic ratio from patient serum in the search of predictive biomarkers for EGFR inhibitor-mediated skin rashIn: European Journal of Cancer (EJC), Jg. 55, 2016, S. 131 – 139
-
N-glycosylation heterogeneity and the influence on structure, function and pharmacokinetics of monoclonal antibodies and Fc fusion proteinsIn: European Journal of Pharmaceutics and Biopharmaceutics, Jg. 100, 2016, S. 94 – 100DOI (Open Access)
-
Paul Ehrlich (1854-1915) and His Contributions to the Foundation and Birth of Translational MedicineIn: Journal of Innate Immunity, Jg. 8, 2016, Nr. 2, S. 111 – 120
-
Adverse events during placebo vs. no drug administration : results of a randomised interventional trial in 160 volunteersIn: European Journal of Clinical Pharmacology, Jg. 71, 2015, Nr. 11, S. 1403 – 1405
-
Comparability of Biosimilar Filgrastim with Originator Filgrastim: : Protein Characterization, Pharmacodynamics, and PharmacokineticsIn: BioDrugs, Jg. 29, 2015, Nr. 2, S. 123 – 131DOI (Open Access)
-
In Memoriam : William A. CraigIn: Antimicrobial Agents and Chemotherapy, Jg. 59, 2015, Nr. 6, S. 2971DOI (Open Access)
-
N-glycan PK Profiling Using a High Sensitivity nanoLCMS Work-Flow with Heavy Stable Isotope Labeled Internal Standard and Application to a Preclinical Study of an IgG1 BiopharmaceuticalIn: Pharmaceutical Research, Jg. 32, 2015, Nr. 11, S. 3649 – 3659DOI (Open Access)
-
Shape does matter : short high-concentration exposure minimizes resistance emergence for fluoroquinolones in Pseudomonas aeruginosaIn: Journal of Antimicrobial Chemotherapy, Jg. 70, 2015, Nr. 3, S. 818 – 826DOI (Open Access)
-
Challenges of surveying wastewater drug loads of small populations and generalizable aspects on optimizing monitoring designIn: Addiction, Jg. 109, 2014, Nr. 3, S. 472 – 481
-
Evaluation of imipenem for prophylaxis and therapy of yersinia pestis delivered by aerosol in a mouse model of pneumonic plagueIn: Antimicrobial Agents and Chemotherapy, Jg. 58, 2014, Nr. 6, S. 3276 – 3284DOI, Online Volltext (Open Access)
-
FOLFIRI and sunitinib as first-line treatment in metastatic colorectal cancer patients with liver metastases--a CESAR phase II study including pharmacokinetic, biomarker, and imaging dataIn: International Journal of Clinical Pharmacology and Therapeutics, Jg. 52, 2014, Nr. 8, S. 642 – 652
-
Pharmacokinetics of ertapenem in critically ill patients receiving continuous venovenous hemodialysis or hemodiafiltrationIn: Antimicrobial Agents and Chemotherapy, Jg. 58, 2014, Nr. 3, S. 1320 – 1326DOI, Online Volltext (Open Access)
-
Small scale affinity purification and high sensitivity reversed phase nanoLC-MS N-glycan characterization of mAbs and fusion proteinsIn: mAbs, Jg. 6, 2014, Nr. 4, S. 894 – 903DOI (Open Access)
-
Blood, tissue, and intracellular concentrations of azithromycin during and after end of therapyIn: Antimicrobial Agents and Chemotherapy, Jg. 57, 2013, Nr. 4, S. 1736 – 1742DOI, Online Volltext (Open Access)
-
The therapeutic effect of tigecycline, unlike that of ceftazidime, is not influenced by whether the 'Klebsiella pneumoniae' strain produces extended-spectrum β-lactamases in experimental pneumonia in ratsIn: Antimicrobial Agents and Chemotherapy, Jg. 57, 2013, Nr. 1, S. 643 – 646DOI, Online Volltext (Open Access)
-
Blood, Tissue, and Intracellular Concentrations of Erythromycin and Its Metabolite Anhydroerythromycin during and after TherapyIn: Antimicrobial Agents and Chemotherapy, Jg. 56, 2012, Nr. 2, S. 1059 – 1064
-
Overton's rule helps to estimate the penetration of anti-infectives into patients' cerebrospinal fluidIn: Antimicrobial Agents and Chemotherapy, Jg. 56, 2012, Nr. 2, S. 979 – 988
-
Population pharmacokinetics of piperacillin at two dose levels : Influence of nonlinear pharmacokinetics on the pharmacodynamic profileIn: Antimicrobial Agents and Chemotherapy, Jg. 56, 2012, Nr. 11, S. 5715 – 5723
-
An LC-MS/MS procedure for the quantification of naproxen in human plasma : Development, validation, comparison with other methods, and application to a pharmacokinetic studyIn: Journal of Chromatography B, Jg. 879, 2011, Nr. 19, S. 1686 – 1696
-
Biomarker response on exposure to sunitinib and its primary metabolite (SU12662) in metastatic colorectal cancer patientsIn: International Journal of Clinical Pharmacology and Therapeutics, Jg. 49, 2011, Nr. 1, S. 88 – 90
-
Comparable Population Pharmacokinetics and Pharmacodynamic Breakpoints of Cefpirome in Cystic Fibrosis Patients and Healthy VolunteersIn: Antimicrobial Agents and Chemotherapy, Jg. 55, 2011, Nr. 6, S. 2927 – 2936DOI, Online Volltext (Open Access)
-
Development and validation of a liquid chromatography/tandem mass spectrometry procedure for the quantification of sunitinib (SU11248) and its active metabolite, N-desethyl sunitinib (SU12662), in human plasma : Application to an explorative studyIn: Journal of Chromatography B, Jg. 879, 2011, Nr. 11-12, S. 695 – 706
-
Penetration of meropenem into epithelial lining fluid of patients with ventilator-associated pneumoniaIn: Antimicrobial Agents and Chemotherapy, Jg. 55, 2011, Nr. 4, S. 1606 – 1610
-
Population pharmacokinetics and penetration into prostatic, seminal, and vaginal fluid for ciprofloxacin, levofloxacin, and their combinationIn: Chemotherapy, Jg. 57, 2011, Nr. 5, S. 402 – 416
-
Bioequivalence studies of Omnitrope, the first biosimilar/rhGH follow-on protein : Two comparative phase 1 randomized studies and population pharmacokinetic analysisIn: Journal of Clinical Pharmacology, Jg. 50, 2010, Nr. 11, S. 1339 – 1348
-
Comparison of 30-min and 3-h infusion regimens for imipenem/cilastatin and for meropenem evaluated by Monte Carlo simulationIn: Diagnostic Microbiology and Infectious Disease, Jg. 68, 2010, Nr. 3, S. 251 – 258
-
Competitive inhibition of renal tubular secretion of ciprofloxacin and metabolite by probenecidIn: British Journal of Clinical Pharmacology (BJCP), Jg. 69, 2010, Nr. 2, S. 167 – 178
-
Development of a new G-CSF product based on biosimilarity assessmentIn: Annals of Oncology, Jg. 21, 2010, Nr. 7, S. 1419 – 1429DOI (Open Access)
-
Inhibition of hyaluronan synthesis accelerates murine atherosclerosis : Novel insights into the role of hyaluronan synthesisIn: Circulation, Jg. 122, 2010, Nr. 22, S. 2313 – 2322
-
Nonlinear pharmacokinetics of piperacillin in healthy volunteers - implications for optimal dosage regimensIn: British Journal of Clinical Pharmacology (BJCP), Jg. 70, 2010, Nr. 5, S. 682 – 693
-
Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infectionsIn: Clinical Microbiology Reviews, Jg. 23, 2010, Nr. 4, S. 858 – 883DOI (Open Access)
-
Physicochemical and biologic comparability of a biosimilar granulocyte colony-stimulating factor with its reference productIn: BioDrugs, Jg. 24, 2010, Nr. 6, S. 347 – 357
-
Population pharmacokinetic comparison and pharmacodynamic breakpoints of ceftazidime in cystic fibrosis patients and healthy volunteersIn: Antimicrobial Agents and Chemotherapy, Jg. 54, 2010, Nr. 3, S. 1275 – 1282
-
Absorption of intravesically applied drugs : Comparison of normal and ileal augmented rabbit bladderIn: The Journal of Urology, Jg. 172, 2004, Nr. 5, S. 2045 – 2050
-
Pharmacokinetics and Pharmacodynamics of Antibiotics in BoneIn: Bone and Joint Infections: From Microbiology to Diagnostics and Treatment / Zimmerli, Werner (Hrsg.): Wiley, 2021
-
Pharmacokinetics and Pharmacodynamics of Antibiotics in BoneIn: Bone and Joint Infections: From Microbiology to Diagnostics and Treatment / Zimmerli, Werner. Chichester, West Sussex: Wiley Blackwell, 2015, S. 21 – 37